glp-1 news 2025 october 16 Who Gets the Shot? Access by State GLP-1 Drug Pipeline 2026 |

Approval was based on phase 3 clinical data particularly from the OASIS 4 trial showing

Research indicates that people with opioid use disorder who take GLP-1 medications experience a 40 percent decrease in their risk of opioid overdose, says Dr

it reflects real neurobiological activity, since GLP-1 receptors are expressed in reward circuitry including the mesolimbic dopamine system, and we should be taking that seriously

Wellstar was one of our partnering health systems in the Get Screened initiative

Beyond biology, factors like body image, confidence, and relationship dynamics also play a major role

I have a mechanistically plausible intervention with minimal risk